Literature DB >> 28616304

Tailored antiplatelet therapy in high-risk ACS patients treated with PCI stenting: lessons from the ANTARCTIC trial.

Nathan Messas1, Jean-François Tanguay1,2, Marie Lordkipanidzé3,4.   

Abstract

Entities:  

Year:  2017        PMID： 28616304      PMCID： PMC5465104          DOI： 10.21037/jtd.2017.04.46

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

1.  Relationship between platelet reactivity inhibition and non-CABG related major bleeding in patients undergoing percutaneous coronary intervention.

Authors:  Omar Ait Mokhtar; Gilles Lemesle; Sébastien Armero; Julien Mancini; Caroline Bonello; Iliassou Tahirou; Paul Barragan; Françoise Dignat-George; Laurence Camoin-Jau; Franck Paganelli; Laurent Bonello
Journal:  Thromb Res       Date:  2010-02-02       Impact factor: 3.944

Review 2.  Platelet Function Tests.

Authors:  Marie Lordkipanidzé
Journal:  Semin Thromb Hemost       Date:  2016-02-29       Impact factor: 4.180

3.  Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents.

Authors:  Kengo Tsukahara; Kazuo Kimura; Satoshi Morita; Toshiaki Ebina; Masami Kosuge; Kiyoshi Hibi; Jun Okuda; Noriaki Iwahashi; Nobuhiko Maejima; Tatsuya Nakachi; Fumiyuki Ohtsuka; Katsutaka Hashiba; Yoshio Tahara; Teruyasu Sugano; Satoshi Umemura
Journal:  Circ J       Date:  2010-02-20       Impact factor: 2.993

4.  Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.

Authors:  Udaya S Tantry; Laurent Bonello; Daniel Aradi; Matthew J Price; Young-Hoon Jeong; Dominick J Angiolillo; Gregg W Stone; Nick Curzen; Tobias Geisler; Jurrien Ten Berg; Ajay Kirtane; Jolanta Siller-Matula; Elisabeth Mahla; Richard C Becker; Deepak L Bhatt; Ron Waksman; Sunil V Rao; Dimitrios Alexopoulos; Rossella Marcucci; Jean-Luc Reny; Dietmar Trenk; Dirk Sibbing; Paul A Gurbel
Journal:  J Am Coll Cardiol       Date:  2013-09-27       Impact factor: 24.094

5.  Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study).

Authors:  Giuseppe Patti; Vincenzo Pasceri; Vincenzo Vizzi; Elisabetta Ricottini; Germano Di Sciascio
Journal:  Am J Cardiol       Date:  2011-01-20       Impact factor: 2.778

6.  Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.

Authors:  Matthew J Price; Peter B Berger; Paul S Teirstein; Jean-François Tanguay; Dominick J Angiolillo; Douglas Spriggs; Sanjeev Puri; Mark Robbins; Kirk N Garratt; Olivier F Bertrand; Michael E Stillabower; Michael E Stillablower; Joseph R Aragon; David E Kandzari; Curtiss T Stinis; Michael S Lee; Steven V Manoukian; Christopher P Cannon; Nicholas J Schork; Eric J Topol
Journal:  JAMA       Date:  2011-03-16       Impact factor: 56.272

7.  A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study.

Authors:  Dietmar Trenk; Gregg W Stone; Meinrad Gawaz; Adnan Kastrati; Dominick J Angiolillo; Ulrike Müller; Gert Richardt; Joseph A Jakubowski; Franz-Josef Neumann
Journal:  J Am Coll Cardiol       Date:  2012-04-18       Impact factor: 24.094

8.  Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement.

Authors:  D Sibbing; S Schulz; S Braun; T Morath; J Stegherr; J Mehilli; A Schömig; N von Beckerath; A Kastrati
Journal:  J Thromb Haemost       Date:  2009-11-28       Impact factor: 5.824

9.  A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.

Authors:  Dirk Sibbing; Dániel Aradi; Claudius Jacobshagen; Lisa Gross; Dietmar Trenk; Tobias Geisler; Martin Orban; Tommaso Gori; Martin Hadamitzky; Béla Merkely; Róbert Gábor Kiss; András Komócsi; Csaba A Dézsi; Andreas Thalmeier; Anja Löw; Lesca Holdt; Daniel Teupser; Hüseyin Ince; Stephan B Felix; Radoslaw Parma; Lukasz Malek; Jan Horstkotte; Monika Baylacher; Robert Schwinger; Johannes Rieber; Harald Mudra; Jörg Hausleiter; Kurt Huber; Franz-Josef Neumann; Lukasz Koltowski; Zenon Huczek; Julinda Mehilli; Steffen Massberg
Journal:  Thromb Haemost       Date:  2016-09-22       Impact factor: 5.249

10.  Bedside monitoring to adjust antiplatelet therapy for coronary stenting.

Authors:  Jean-Philippe Collet; Thomas Cuisset; Grégoire Rangé; Guillaume Cayla; Simon Elhadad; Christophe Pouillot; Patrick Henry; Pascal Motreff; Didier Carrié; Ziad Boueri; Loic Belle; Eric Van Belle; Hélène Rousseau; Pierre Aubry; Jacques Monségu; Pierre Sabouret; Stephen A O'Connor; Jérémie Abtan; Mathieu Kerneis; Christophe Saint-Etienne; Olivier Barthélémy; Farzin Beygui; Johanne Silvain; Eric Vicaut; Gilles Montalescot
Journal:  N Engl J Med       Date:  2012-11-04       Impact factor: 91.245
View more
  1 in total

1.  Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome.

Authors:  Ilaria Cavallari; Ernesto Maddaloni; Felice Gragnano; Giuseppe Patti; Emilia Antonucci; Paolo Calabrò; Plinio Cirillo; Paolo Gresele; Gualtiero Palareti; Vittorio Pengo; Pasquale Pignatelli; Rossella Marcucci
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.